Mitochondrial STAT3 exacerbates LPS-induced sepsis by driving CPT1a-mediated fatty acid oxidationRongqing Li, Takayuki Ikezoe|Theranostics|2021Cited by 156
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemiaTakayuki Ikezoe, Hirokuni Taguchi|Molecular Cancer Therapeutics|2007Cited by 131
A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: One-year resultsMelissa Wasserstein, Monica Kumar, Carla E. M. Hollak et al.|Genetics in Medicine|2022Cited by 99
Expression of p‐JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemiaTakayuki Ikezoe, Akihito Yokoyama|International Journal of Cancer|2011Cited by 47
Analysis of Aurora B kinase in non-Hodgkin lymphomaTakayuki Ikezoe, Akihito Yokoyama|Laboratory Investigation|2009Cited by 39